Research Directory

What Roche's takeover of Flatiron Health really means

Read more

Innate Pharma aims to regain leadership in IO

Read more

Antibody-degrading enzyme enables transplants

Read more

Mitochondrial quality control as potential therapy

Read more

Building a European capital market

Read more

The new complexity in clinical study protocols

Read more

Cell therapy success and the competition for value

Read more

Why pharma is paying a premium for assets

Read more

Takeovers refocus Sanofi on rare diseases

Read more

How GMO rules affect gene and cell therapies

Read more